C79.02
Secondary malignant neoplasm of left kidney and renal pelvis
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code C79.02 refers to a secondary malignant neoplasm, or metastasis, involving the left kidney and renal pelvis. This condition indicates that cancer originating elsewhere in the body has spread to these structures. The discovery of a secondary tumor often indicates an advanced stage of cancer, requiring comprehensive medical evaluation and treatment planning. It is essential to understand the nature of secondary tumors, their causes, symptoms, and treatment options to better grasp how this condition impacts health.
Causes & Symptoms
Clinical Causes: Primary cancers from other body parts that have spread to the kidney and renal pelvis, such as lung, breast, colorectal, or melanoma cancers. Hematogenous spread, where cancer cells circulate through the bloodstream to reach the kidney and renal pelvis. Lymphatic spread from nearby or distant lymph nodes affected by primary tumors. Genetic factors or mutations that increase the risk of metastatic disease. Previous history of cancer, which may have metastasized after initial treatment.
Key Symptoms: Hematuria (blood in the urine), which can be painless or associated with discomfort. Flank pain or a dull ache in the side of the abdomen where the kidney is located. Unexplained weight loss and fatigue, common signs of advanced cancer. A palpable mass or swelling in the flank area. Fever that might be persistent and not due to infection. General malaise or a feeling of being unwell.
Diagnostic & Treatment
Diagnosis Path: Diagnosing secondary malignant neoplasm of the kidney and renal pelvis involves multiple steps: - Imaging tests such as CT scans, MRI, and ultrasound to identify the location and extent of metastatic lesions. - Laboratory tests including blood work to assess overall health and organ function. - Biopsy procedures where tissue samples are taken from the affected area to confirm cancer type and origin. - Additional imaging like PET scans to detect other metastatic sites and evaluate the spread of the disease. - Reviewing patient history and previous diagnoses to determine the primary cancer source.
Treatment Protocols: Management of secondary malignant neoplasm involving the left kidney and renal pelvis depends on several factors, including the primary cancer type, extent of spread, patient health status, and symptoms. Treatment options typically include: - Systemic therapies such as chemotherapy, targeted therapy, or immunotherapy aimed at controlling the primary cancer and metastases. - Surgical intervention may be considered to remove kidney tissue affected by metastasis, especially if it is causing significant symptoms or complications. - Palliative treatments to relieve symptoms and improve quality of life, including pain management and supportive care. - Radiation therapy in certain cases to reduce tumor size and control symptoms. The treatment plan is usually tailored to the individual needs and overall health of the patient, requiring close collaboration among oncology specialists and other healthcare providers.
Clinical Advice & FAQs
Billing Guidance
Is C79.02 a billable ICD-10 code?
Yes, C79.02 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C79.02?
Clinical documentation must specify the nature of Secondary malignant neoplasm of left kidney and renal pelvis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
